Electrolyte and Fluid Disturbances in Subarachnoid Hemorrhage and Traumatic Brain Injury

Sponsor
University Hospital Inselspital, Berne (Other)
Overall Status
Completed
CT.gov ID
NCT01313975
Collaborator
Foundation for research in Anaesthesie and Intensive Care Medicine (Other), Brahms AG (Industry)
85
1
24
3.5

Study Details

Study Description

Brief Summary

During the course of their acute illness patients with subarachnoid hemorrhage and severe traumatic brain injury often develop disturbances in their fluid balance and electrolyte homeostasis. These shifts are associated with worse outcome and increased morbidity.

The aim of this observational study is to systematically analyze the incidence, characteristics, potential diagnostic markers and predisposing factors of such disturbances. The investigators hypothesize that many disturbances cannot be classified with a standard diagnostic approach and that variable fluid management contributes to their pathophysiology.

Patients will be closely monitored clinically and the exact fluid and electrolyte balances will be recorded. Treatment decisions are within the bedside physicians responsibility. Baseline fluid management is standardised. No interventions are planned. The observation period equal the duration of ICU stay.

Detailed Description

Background

Electrolyte disturbances and fluid shifts are common in patients with subarachnoid hemorrhage (SAH) or traumatic brain injury (TBI). They usually have a rapid onset with impact on morbidity (possibly mortality) and length of stay. So far the understanding of underlying pathophysiologies and the contribution of iatrogenic influences is not fully understood.

Only limited evidence and data on classification, management and outcome of patients exists.

Objective

To describe the incidence, characteristics and duration of sodium and fluid disturbances in patients with SAH or TBI.

To document exact fluid and electrolyte management To evaluate predisposing factors and potential predicting biomarkers such as natriuretic peptides, renin-aldosterone system.

Methods

Prospective systematic observational study with 50 patients in the SAH group and 50 patients in the TBI group.

8hourly clinical assessment, blood and urin samples. Defined trigger points for additional measurements.

Continuous fluid balance documentation Daily measurement of natriuretic peptides, aldosterone and renin

Study Design

Study Type:
Observational
Actual Enrollment :
85 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Disturbances of the Sodium and Fluid Balance in Patients With Severe Traumatic Brain Injury and Non-traumatic Subarachnoid Hemorrhage. A Systematic Observational Study
Study Start Date :
Jan 1, 2011
Actual Primary Completion Date :
Jan 1, 2013
Actual Study Completion Date :
Jan 1, 2013

Arms and Interventions

Arm Intervention/Treatment
1

Patients with non-traumatic subarachnoid hemorrhage

2

Patients with severe traumatic brain injury

Outcome Measures

Primary Outcome Measures

  1. Incidence of sodium-fluid disturbances [14 days]

Secondary Outcome Measures

  1. Type of sodium abnormality [14 days]

  2. Haemodynamic changes, 8hourly urine output, 8hourly fluid and sodium balance, changes in fluid management by treating doctors associated with sodium disturbances [14 days]

    We measure all parameters for multivariate analysis to find common predictors for sodium and fluid balance disturbances in these patients

  3. Associated changes in natriuretic peptide levels [14 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • non-traumatic subarachnoid hemorrhage

  • severe traumatic brain injury (GCS<9)

Exclusion Criteria

  • younger than 18 years

  • time to admission after injury or bleed more than 7days

  • death expected in less than 12hours

Contacts and Locations

Locations

Site City State Country Postal Code
1 Dep. of Intensive Care Medicine Bern University Hospital Bern Switzerland 3010

Sponsors and Collaborators

  • University Hospital Inselspital, Berne
  • Foundation for research in Anaesthesie and Intensive Care Medicine
  • Brahms AG

Investigators

  • Principal Investigator: Jan Wiegand, MD, Dep. Intensive Care Medicine, University Hospitals Bern
  • Study Director: Stephan Jakob, MD, PhD, Dep. Intensive Care Medicine, University Hospitals Bern
  • Study Chair: Jukka Takala, MD PhD, Dep. Intensive Care Medicine, University Hospitals Bern

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01313975
Other Study ID Numbers:
  • 203/10
First Posted:
Mar 14, 2011
Last Update Posted:
Apr 17, 2013
Last Verified:
Apr 1, 2013

Study Results

No Results Posted as of Apr 17, 2013